Skip to main content
Premium Trial:

Request an Annual Quote

Asa Ren, G42 Healthcare Partner to Promote Genomics, Bioinformatics in Indonesia

NEW YORK – Indonesian genotyping company Asa Ren said Thursday that it formed a partnership with G42 Healthcare to develop and promote genomic sequencing and bioinformatics in Indonesia in support of the country's Biomedical and Genome Science Initiative. The partners signed their memorandum of understanding at a side event to the Group of 20 summit in Jakarta, Indonesia, that wrapped up Wednesday.

The firms will employ microarray genotyping and whole-genome sequencing as Indonesia seeks to build infrastructure for precision medicine. They also expect to create a genome biobank as well as a next-generation sequencing analytics pipeline.

"Together, this partnership will drive a transformation in Indonesia's genomic industry and elevate the entire healthcare and biotech ecosystem to deliver long-term value with both G42 Healthcare and Asa Ren's combined technologies and expertise," Asa Ren CEO Aloysius Liang said in a statement.

"Our partnership with Asa Ren will enable support of the national genomics initiatives and realize the shared vision of delivering comprehensive genome data, biological insights, and healthcare outcomes for personalized and preventive healthcare delivery in Indonesia," said Ashish Koshy, CEO of G42 Healthcare.

G42 Healthcare, based in Abu Dhabi, is a health tech company that aims to develop the healthcare sector in the United Arab Emirates and beyond using artificial intelligence, scientific research, and technology in genomics, digital health, diagnostics, and clinical trials.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.